ENDRA Life Sciences (NDRA) Net Cash Flow Growth (5y) (2021 - 2026)
ENDRA Life Sciences (NDRA) Net Cash Flow Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.35% |
| Dec 31, 2025 | -14.98% |
| Sep 30, 2025 | -18.47% |
| Jun 30, 2025 | 35.82% |
| Mar 31, 2025 | 17.63% |
| Dec 31, 2024 | -19.02% |
| Sep 30, 2024 | -192.75% |
| Jun 30, 2024 | 38.93% |
| Mar 31, 2024 | 7.77% |
| Dec 31, 2023 | -15.84% |
| Sep 30, 2023 | 1.09% |
| Jun 30, 2023 | 35.75% |
| Mar 31, 2023 | -0.66% |
| Dec 31, 2022 | -17.85% |
| Sep 30, 2022 | -42.94% |
| Jun 30, 2022 | -10.90% |
| Mar 31, 2022 | -190.54% |
| Dec 31, 2021 | -33.68% |
| Sep 30, 2021 | -69.60% |
| Jun 30, 2021 | -50.76% |